Urinary Macrophage Migration Inhibitory Factor as a Noninvasive Biomarker in Pediatric Henoch-Schönlein Purpura Nephritis
暂无分享,去创建一个
Jiapei Wang | Yazhen Di | Qianqian Ying | Yuanling Chen | Xiahua Dai | Mengjiao Shen | Yunyan Li | Shiwei Fu | Yinjie Li
[1] B. Tsao,et al. Artesunate inhibits type I interferon-induced production of macrophage migration inhibitory factor in patients with systemic lupus erythematosus , 2017, Lupus.
[2] L. Leng,et al. Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL‐1β production in a murine model of acute gout , 2016, Journal of leukocyte biology.
[3] Kyoung-Woon Kim,et al. Macrophage migration inhibitory factor: a potential therapeutic target for rheumatoid arthritis , 2016, The Korean journal of internal medicine.
[4] R. Zwiech. Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis , 2015, BMC Immunology.
[5] M. Chimenti,et al. Vasculitides and the Complement System: a Comprehensive Review , 2015, Clinical Reviews in Allergy & Immunology.
[6] M. Pohl. Henoch–Schönlein purpura nephritis , 2015, Pediatric Nephrology.
[7] R. Coppo,et al. Henoch–Schönlein purpura nephritis in children , 2014, Nature Reviews Nephrology.
[8] M. Nowicki,et al. Polymorphic variants of MIF gene and prognosis in steroid therapy in children with idiopathic nephrotic syndrome. , 2014, Acta biochimica Polonica.
[9] N. Tomioka,et al. Macrophage migration inhibitory factor is a possible candidate for the induction of microalbuminuria in diabetic db/db mice. , 2013, Biological & pharmaceutical bulletin.
[10] Chiou-Feng Lin,et al. Urinary Macrophage Migration Inhibitory Factor Serves as a Potential Biomarker for Acute Kidney Injury in Patients with Acute Pyelonephritis , 2012, Mediators of inflammation.
[11] T. Jahnukainen,et al. Outcome of Henoch–Schönlein purpura 8 years after treatment with a placebo or prednisone at disease onset , 2012, Pediatric Nephrology.
[12] V. Jeevanandam,et al. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. , 2010, American Society of Nephrology. Clinical Journal.
[13] R. Dodel,et al. Macrophage Migration Inhibitory Factor in Normal Human Skeletal Muscle and Inflammatory Myopathies , 2010, Journal of neuropathology and experimental neurology.
[14] A. Bakkaloğlu,et al. EULAR/PRINTO/PRES criteria for Henoch–Schönlein purpura, childhood polyarteritis nodosa, childhood Wegener granulomatosis and childhood Takayasu arteritis: Ankara 2008. Part II: Final classification criteria , 2010, Annals of the rheumatic diseases.
[15] H. Lan. Role of Macrophage Migration Inhibition Factor in Kidney Disease , 2008, Nephron Experimental Nephrology.
[16] M. Hickey,et al. Targeting leukocytes in immune glomerular diseases. , 2008, Current medicinal chemistry.
[17] O. Kemmotsu,et al. Role of macrophage migration inhibitory factor in acute lung injury in mice with acute pancreatitis complicated by endotoxemia. , 2006, American journal of respiratory cell and molecular biology.
[18] H. Narchi. Risk of long term renal impairment and duration of follow up recommended for Henoch-Schönlein purpura with normal or minimal urinary findings: a systematic review , 2005, Archives of Disease in Childhood.
[19] K. Matsumoto,et al. Elevated macrophage migration inhibitory factor (MIF) levels in the urine of patients with focal glomerular sclerosis , 2005, Clinical and experimental immunology.
[20] M. Lam,et al. Anti-macrophage migration inhibitory factor reduces transforming growth factor-beta 1 expression in experimental IgA nephropathy. , 2004, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[21] Y. Kawasaki,et al. Clinical and pathological features of children with Henoch-Schoenlein purpura nephritis: risk factors associated with poor prognosis. , 2003, Clinical nephrology.
[22] K. Lai,et al. Polymeric IgA increases the synthesis of macrophage migration inhibitory factor by human mesangial cells in IgA nephropathy. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[23] R. Atkins,et al. Urine macrophage migration inhibitory factor reflects the severity of renal injury in human glomerulonephritis. , 2002, Journal of the American Society of Nephrology : JASN.
[24] R. Atkins,et al. The Pathogenic Role of Macrophage Migration Inhibitory Factor in Immunologically Induced Kidney Disease in the Rat , 1997, The Journal of experimental medicine.
[25] B. Bloom,et al. Mechanism of a Reaction in Vitro Associated with Delayed-Type Hypersensitivity , 1966, Science.